Two scientists made huge bets on ‘impossible’ cancer treatments. They’re finally paying off.
Short sellers love to profit from biotech's big fails.The category remains their favorite to…
The Enhanced Games — tech’s steroid extravaganza — didn’t pay off, as company posts $60 million loss
The event ended up being more than a little anticlimactic. Hailed by its creators…
Dimension Capital’s $800M third fund shows the intersection of science and compute is booming
While many newer VC firms are still struggling to raise fresh capital, Dimension Capital,…
What happens in Vega$: steroids, swimmers, and a billion-dollar hustle
I am sitting in the sweltering Nevada heat watching a man struggle to lift…
I went to the so-called ‘steroid Olympics,’ to understand why Silicon Valley is obsessed with peptides
I am sitting in the sweltering Nevada heat watching a man struggle to lift…
This young startup is taking on a fragrance industry that hasn’t changed in almost half a century
Fragrance tech company Patina says it has raised $2 million in funding investors, including…
Imperagen raises £5 million to use quantum physics, AI on enzyme engineering
Biotech company Imperagen announced on Thursday a £5 million ($6.7 million) seed round led…
